aldesleukin 22,000,000 UNT Injection

RxCUI
307816
RxNorm name
aldesleukin 22,000,000 UNT Injection
Display name
aldesleukin 22,000,000 UNT Injection
Full name
aldesleukin 22,000,000 UNT Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:57

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
103293Proleukinaldesleukin351(a)Rx2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PROLEUKINALDESLEUKINIovance Biotherapeutics, Incf3c516ad-d405-4fbe-af6a-962080dbfa7d2024-12-20Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 307816

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
4e2b687e-47f2-4f3c-80ab-e3224befffcaaldesleukin 22,000,000 UNT Injection [PSN] · aldesleukin 22000000 UNT Injection [SCD] · aldesleukin 1.3 MG Injection [SY] · aldesleukin 22,000,000 UNT Injection [SY]415PROLEUKIN®20190523
f3c516ad-d405-4fbe-af6a-962080dbfa7daldesleukin 22,000,000 UNT Injection [PSN] · aldesleukin 22000000 UNT Injection [SCD] · aldesleukin 1.3 MG Injection [SY] · aldesleukin 22,000,000 UNT Injection [SY]47These highlights do not include all the information needed to use PROLEUKIN ® safely and effectively. See full prescribing information for PROLEUKIN. PROLEUKIN (aldesleukin) for injection, for intravenous use Initial U.S. Approval: 199220241220